日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antitumoral immunity induced by gel ethanol ablation to treat unresectable colorectal cancer metastases in the liver

利用凝胶乙醇消融术诱导抗肿瘤免疫治疗无法切除的肝转移性结直肠癌

Yang, Jeffrey; Morhard, Robert; Huth, Hannah; Karim, Baktiar; Karanian, John W; Wood, Bradford J; Mikhail, Andrew S; Mueller, Jenna L

Metabolic dependency mapping identifies Peroxiredoxin 1 as a driver of resistance to ATM inhibition

代谢依赖性图谱分析表明,过氧化物酶1是ATM抑制剂耐药性的驱动因素。

Li, Haojian; Furusawa, Takashi; Cavero, Renzo; Xiao, Yunjie; Chari, Raj; Wu, Xiaolin; Sun, David; Hartmann, Oliver; Dhall, Anjali; Holewinski, Ronald; Andresson, Thorkell; Karim, Baktiar; Villamor-Payà, Marina; Gallardo, Devorah; Day, Chi-Ping; Pal, Lipika R; Nair, Nishanth Ulhas; Ruppin, Eytan; Aladjem, Mirit I; Pommier, Yves; Diefenbacher, Markus E; Lim, Jung Mi; Levine, Rodney L; Stracker, Travis H; Weyemi, Urbain

Targeting c-MYC and gain-of-function p53 through inhibition or degradation of the kinase LZK suppresses the growth of HNSCC tumors.

通过抑制或降解激酶 LZK 来靶向 c-MYC 和获得功能的 p53,可以抑制 HNSCC 肿瘤的生长

Funk Amy L, Katerji Meghri, Afifi Marwa, Nyswaner Katherine, Woodroofe Carolyn C, Edwards Zoe C, Lindberg Eric, Bergman Knickole L, Gough Nancy R, Rubin Maxine R, Karpińska Kamila, Trotter Eleanor W, Dash Sweta, Ries Amy L, James Amy, Robinson Christina M, Difilippantonio Simone, Karim Baktiar O, Chang Ting-Chia, Chen Li, Xu Xin, Doroshow James H, Ahel Ivan, Marusiak Anna A, Swenson Rolf E, Cappell Steven D, Brognard John

Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82.

利用新型 NAMPT 抑制剂 OT-82 靶向 FH 缺陷型遗传性平滑肌瘤病和肾细胞癌中的 NAD+ 代谢脆弱性

Najera Susana S, Ricketts Christopher J, Schmidt Laura S, Medina Julia I, Saito Keita, Ileva Lilia, Brender Jeffrey R, James Amy M, Peer Cody J, Gouker Brad, Karim Baktiar O, Chernova Olga, Wells Catherine, Wei Ming-Hui, Yang Youfeng, Zhang Xiaohu, Klumpp-Thomas Carleen, Travers Jameson, Chen Lu, Wilson Kelli M, Issaq Sameer H, Figg William D, Difilippantonio Simone, Kalen Joseph D, Krishna Murali C, Thomas Craig J, Ceribelli Michele, Heske Christine M, Crooks Daniel R, Meier Jordan L

The elevated expression of ORF75, a KSHV lytic gene, in Kaposi sarcoma lesions is driven by a GC-rich DNA cis element in its promoter region.

卡波西肉瘤病变中 KSHV 裂解基因 ORF75 的高表达是由其启动子区域中富含 GC 的 DNA 顺式元件驱动的

Nair Ashwin, Davis David A, Warner Andrew, Karim Baktiar, Ramaswami Ramya, Yarchoan Robert

A simple circuit to sustain intact tumor microenvironments for complex drug interrogations

一种用于维持完整肿瘤微环境以进行复杂药物研究的简单电路

Sarvestani, A Leila; Ruff, Samantha; Remmert, Kirsten; Teke, Martha; Verbus, Emily; Saif, Areeba; Garmendia-Cedillos, Marcial; Rossi, Alex; Rainey, Ashley; Nomie, Krystle; Sinha, Surajit; Wach, Michael M; Ryan, Carrie; Gregory, Stephanie N; Desai, Priyanka; Panda, Abir K; Smith, Emily C; Ayabe, Reed; McDonald, James D; Gupta, Shreya; Pu, Tracey; Khan, Tahsin; Lambdin, Jacob; Luberice, Kenneth; Lux, Stephanie C; Hong, Hanna; Alexander, Imani; Akmal, Sarfraz R; Rehman, Shahyan; Xiao, Sophia; Ho, Jason; Burke, Justine; Hannah, Cathleen E; Livanova, Alexandra; Tyshevich, Andrey; Kurpe, Stanislav; Kravets, Andrey; Salem, Basim; Vibe, Daniil; Tkachukv, Arina; Belozerova, Anna; Sarachakov, Aleksandr; Barykin, Evgeny; Kushnarev, Vladimir; Postovalova, Ekaterina; Bagaev, Alexander; Kedei, Noemi; Hernandez, Maria; Karim, Baktiar; Butcher, Donna; Matta, Jennifer; Kelly, Michael; Singh, Jatinder; Prickett, Todd D; Hodge, James; Andresson, Thorkell; Yaffe, Michael B; Shevach, Ethan M; Kleiner, David; Davis, Jeremy L; Blakely, Andrew M; Hernandez, Jonathan M

Angulin-1/LSR inhibition transiently disrupts the blood-tumor barrier to enhance doxil permeability and impair malignant glioma progression.

Angulin-1/LSR 抑制剂可暂时破坏血肿瘤屏障,从而增强多柔比星的渗透性并阻碍恶性胶质瘤的进展。

Ferguson Dominique, Kwak Minhye, Lim Sanghee, Cesaire Melissa, Mills Jatia, Dalmage Mahalia, Jones Jane, Tarasov Sergey, Dyba Marzena, Robey Rob, Yang Yanbo, Simpson Shae K, Karim Baktiar, Butcher Donna, Gartrell Robyn, Gottesman Michael, Jackson Sadhana

SRSF3 is oncogenic in breast but tumor-suppressive in liver by differential regulation of gene expression.

SRSF3 在乳腺中具有致癌性,但在肝脏中通过差异性调控基因表达发挥抑癌作用

Yu Lulu, Ajiro Masahiko, Lobanov Alexei, Cam Maggie, Majerciak Vladimir, Karim Baktiar, Gotte Deanna, Deng Chu-Xia, Lowy Douglas R, Webster Nicholas J G, Zheng Zhi-Ming

Carrier-Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery

用于增强光动力癌症治疗和脑部药物递送的无载体非晶态维替泊芬纳米药物

Quinlan, John A; Inglut, Collin T; Srivastava, Payal; Rahman, Idrisa; Stabile, Jillian; Gaitan, Brandon; Arnau Del Valle, Carla; Baumiller, Kaylin; Gaur, Anandita; Chiou, Wen-An; Karim, Baktiar; Connolly, Nina; Robey, Robert W; Woodworth, Graeme F; Gottesman, Michael M; Huang, Huang-Chiao

Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

更正:增强肿瘤中HLADR、CXCL9和CXCL10的表达可能改善嗅觉神经母细胞瘤的免疫治疗反应

Larkin, Riley M; Lopez, Diana C; Robbins, Yvette L; Lassoued, Wiem; Canubas, Kenneth; Warner, Andrew; Karim, Baktiar; Vulikh, Ksenia; Hodge, James W; Floudas, Charalampos S; Gulley, James L; Gallia, Gary L; Allen, Clint T; London, Nyall R Jr